IRIS
BARILLARI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.000
EU - Europa 1.644
AS - Asia 348
AF - Africa 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 28.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.990
DE - Germania 407
UA - Ucraina 391
IE - Irlanda 283
CN - Cina 261
IT - Italia 151
GB - Regno Unito 90
FR - Francia 89
PL - Polonia 88
SE - Svezia 40
RU - Federazione Russa 37
KR - Corea 33
FI - Finlandia 29
TW - Taiwan 19
JP - Giappone 13
BE - Belgio 12
CA - Canada 9
HK - Hong Kong 7
ES - Italia 6
NL - Olanda 5
AL - Albania 4
DK - Danimarca 3
EU - Europa 3
IN - India 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
LV - Lettonia 2
SG - Singapore 2
TR - Turchia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LK - Sri Lanka 1
MA - Marocco 1
RO - Romania 1
Totale 28.008
Salva come PNG Salva come JPEG
Città #
Wilmington 7.694
Woodbridge 7.441
Houston 6.806
Fairfield 628
Chandler 577
Ann Arbor 393
Dearborn 318
Ashburn 272
Dublin 263
Seattle 225
Cambridge 211
Jacksonville 207
Medford 201
New York 153
Beijing 108
Lawrence 94
Kraków 88
Menlo Park 70
Zhengzhou 67
San Diego 52
Rome 48
Boardman 23
Milan 20
Redwood City 20
Mülheim 19
Nanjing 16
Norwalk 15
Verona 13
Brussels 12
Mountain View 12
Phoenix 10
Center 9
Guangzhou 8
Kaohsiung 8
London 8
Shanghai 8
University Park 7
Frankfurt Am Main 6
Hefei 6
Mcallen 6
San Francisco 6
San Mateo 6
Toronto 6
Wuhan 6
Ayn 5
Kunming 5
Moscow 5
Redmond 5
Colorado Springs 4
Engelhard 4
Foggia 4
Frankfurt am Main 4
Halle 4
Indiana 4
Palo Alto 4
Seoul 4
Baotou 3
Cedarhurst 3
Hounslow 3
Lappeenranta 3
Los Angeles 3
Magenta 3
Osaka 3
Prescot 3
Sacramento 3
Shenyang 3
Tirana 3
Washington 3
Beachwood 2
Cairo 2
Cesano Maderno 2
Chengdu 2
Columbus 2
Durban 2
Farmington 2
Fremont 2
Fuzhou 2
Gaeta 2
Guilford 2
Hebei 2
Helsinki 2
Hong Kong 2
Jiaxing 2
Jinan 2
Kelowna 2
Kilburn 2
La Veta 2
Las Rozas de Madrid 2
Leipzig 2
Manchester 2
Manitou Springs 2
Mantova 2
Modena 2
Nürnberg 2
Orta di Atella 2
Paris 2
Pontedera 2
Riga 2
Roseto degli Abruzzi 2
Saint Petersburg 2
Totale 26.318
Salva come PNG Salva come JPEG
Nome #
Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients 460
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia 440
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 434
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. 424
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis 411
Human T-lymphotropic retrovirus infection in Italy 406
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells 401
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway 400
Fibroblast growth factor-2 and the HIV-1 Tat protein synergize in promoting Bcl-2 expression and preventing endothelial cell apoptosis: implications for the pathogenesis of AIDS-associated Kaposi’s sarcoma. 394
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis 388
Pharmacological management of Kaposi’s sarcoma. 387
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles 386
The fibroblast growth factors. 386
Spindle cells from Acquired Immune Deficiency Syndrome-associated Kaposi’s sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2. 385
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells 378
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 376
Antitumor effects of antiretroviral therapy 371
Entrance of the tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels 367
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 363
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis. 358
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16ink4a. 358
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS 355
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma 353
HTLV-I and HIV infection in drug addicts in Italy 352
HIV protease inhibitors as new treatment options for Kaposi's sarcoma 351
Angiogenic properties of human immunodeficiency virus type 1 Tat protein 351
A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo 349
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses 346
null 345
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients 343
Another mechanism involved in AIDS-KS progression. 343
Treatment of Kaposi's sarcoma--an update 343
Pathogenesis of AIDS-associated Kaposi's sarcoma 342
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via proteasome-independent block of angiogenesis and matrix metalloproteinases. 340
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation 330
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth 329
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence 328
Transcription of placenta growth factor type-2 correlates with intratumoral microvessel density in breast carcinomas. 327
HIV protease inhibitors block angiogenesis and promote regression of Kaposi’s sarcoma in the nude mouse model. 324
Human T-lymphotropic retroviruses: a new member of the family. 323
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines 320
Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir 319
Tat, the transactivator gene of HIV-1, activates the expression of tumor necrosis factor-beta. 319
Spindle cells from AIDS-associated Kaposi's sarcoma (KS) lesions express telomerase activity that is enhanced by KS progression factors. 310
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects (TAT domains and pathways for cell growth and transactivation activity). 309
The use of HAART for biological tumour therapy 308
HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population 308
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma 305
Immune activation, rather than immune deficiency, cooperates with HIV infection in the development of AIDS-associated Kaposi’s sarcoma. 305
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles. 303
Basic fibroblast growth factor mediates the growth and angiogenic activity of AIDS-Kaposi’s sarcoma (KS)-derived spindle cells and synergises with HIV-1 Tat protein in inducing KS-like lesions in mice. 303
Release and angiogenic properties of extracellular HIV-1 Tat protein. 298
IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis 297
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor 296
Lymphokines released by activated or HTLV-infected T cells induce growth of normal mesenchymal cells and of cells derived from Kaposi’s sarcoma lesions of AIDS patients. 295
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma 294
HIV-1 Tat protein mimics the effect of extracellular matrix (ECM) protein on vascular cell growth and angiogenesis: implications for AIDS-Kaposi’s sarcoma (AIDS-KS) pathogenesis. 290
Interactions between endothelial cells and HIV-1 287
Biological properties of Human Immunodeficiency Virus type-1 Tat protein: angiogenic effects and adhesive interactions of extracellular Tat. 286
PDGF-B as a possible growth factor in AIDS-KS. 284
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma 282
The formation of new blood vessels in Kaposi’s sarcoma. 281
Mechanism of paclitaxel activity in Kaposi's sarcoma 280
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 277
Basic fibroblast growth factor modifies the interactions between endothelial cells/fibronectin: Implications for progression of AIDS- associated Kaposi's sarcoma 276
Tissue CEA as prognostic indicator in a series of 31 cases of gastric cancer 274
Integrin-mediated uptake of HIV-1 Tat protein by cytokine-activated endothelial cells. 272
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin 270
HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity 269
Biology of Kaposi's sarcoma 269
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis 268
Multicistronic antiangiogenic retroviral vectors for the gene therapy of malignant brain tumors. 264
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects. 264
[Chronic T-lymphocyte lymphatic leukemia. Clinico-pathologic assessment and new epidemiologic data related to cases correlated with HTLV-I in Italy] 264
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines 262
Basic FGF induces lesions in mice resembling KS, and antisense oligonucleotides against this cytokine inhibit the growth and angiogenic activity of KS spindle cells. 260
Cytokines released by activated primary T cells stimulate the growth of AIDS-KS-derived cells and other cells of mesenchymal derivation. 260
Role of cytokines from activated T cells and HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 259
HIV-1 Tat protein enhances angiogenesis and Kaposi’s sarcoma development triggered by inflammatory cytokines or bFGF by engaging the avb3 integrin. 256
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern Europe 253
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. 247
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor 246
Cooperation of HIV-1 Tat protein, inflammatory cytokines or bFGF in the pathogenesis of AIDS-Kaposis’s sarcoma. 244
[HIV protease inhibitors for the treatment of Kaposi's sarcoma] 244
Immune stimulation and HIV-1 infection have complementary effects in the induction and progression of AIDS-associated Kaposi’s sarcoma via release of cytokines and Tat. 242
Inflammatory cytokines increase mesenchymal cell growth and attachment induced by HIV-1 Tat protein and adhesion molecules: implications for AIDS-Kaposi’s sarcoma pathogenesis. 230
Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma. 204
The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs 48
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 45
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 45
HIV-1 tat protein enters dysfunctional endothelial cells via integrins and renders them permissive to virus replication 39
The impact of human papilloma viruses, matrix metallo-proteinases and HIV protease inhibitors on the onset and progression of uterine cervix epithelial tumors: A review of preclinical and clinical studies 33
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 31
Radioresistance in rhabdomyosarcomas: much more than a question of dose 31
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 31
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells 28
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 27
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process 24
Infection by high-risk human papillomaviruses, epithelial-to-mesenchymal transition and squamous pre-malignant or malignant lesions of the uterine cervix: a series of chained events? 20
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 19
Totale 28.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.992
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.702 0 0 0 0 0 0 0 0 0 0 927 775
2019/20207.970 655 663 676 725 765 913 662 620 618 704 509 460
2020/20214.376 485 462 553 554 471 576 523 341 109 75 200 27
2021/2022933 20 135 13 65 19 43 48 120 32 54 85 299
2022/20231.329 160 110 100 143 97 277 114 80 123 43 68 14
2023/2024384 49 13 23 17 38 161 21 12 10 38 2 0
Totale 28.309